Key result
The Western moyamoya phenotype is characterized by distinct clinical associations, including hematologic, congenital, and autoimmune conditions, along with a higher prevalence of ischemic stroke compared to East Asian populations.
Why the study?
Moyamoya in Western countries shows significant divergence in incidence, demographics, presentation, and outcomes compared to East Asian countries, prompting a review to characterize the Western phenotype.
This scoping review characterizes the Western phenotype of moyamoya, highlighting its diverse clinical and symptomatic associations, predominantly neurologic symptoms and stroke.
Answers are grounded in this paper and cite their sources.
May raise suspicion for moyamoya in unexplained ICA stenosis outside East Asia; leaves open incidence and management pending larger studies.
Moyamoya, a rare angiographic finding, is characterized by chronic and progressive stenosis at the terminal end of the internal carotid artery, followed by collateralization of the cerebral vasculature at the base of the skull. Coined by Suzuki and Takaku in 1969, the term "moyamoya" means a "puff of smoke" in Japanese, a reference to the angiographic appearance of moyamoya collateralization. Moyamoya is most commonly found in East Asian countries, where much governmental and civilian effort has been expended to characterize this unique disease process. However, despite its rarity, the occurrence of moyamoya in Western countries is associated with significant divergence regarding incidence, gender, sex, age at diagnosis, clinical presentation, and outcomes. Here, we attempted to review the Western literature on moyamoya presentation using the PubMed database to characterize the Western phenotype of moyamoya. We were guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR). We reviewed papers generated from a search with keywords "moyamoya case report," those reported from a Western institution, and those reported on a relevant association. Our scoping review demonstrated various clinical associations with moyamoya. Moreover, we summarized the demographic profile and clinical symptomatology, as well as reported disease associations to better elucidate the Western phenotype of moyamoya.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2021) conducted a review in Moyamoya disease and syndrome (n=153). Western Moyamoya Phenotype was evaluated on Clinical associations and symptomatology. The Western moyamoya phenotype is characterized by distinct clinical associations, including hematologic, congenital, and autoimmune conditions, along with a higher prevalence of ischemic stroke compared to East Asian populations.
Synapse has enriched 10 related papers. Consider them for comparative context: